UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March~~June 3130, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File No. 001-39660

AJAX I

(Exact name of registrant as specified in its charter)

Cayman Islands

98-1554459

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

667 Madison Avenue
New York, NY 10065

(Address of Principal Executive Offices, including zip code)

(212) 655-2685

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant	AJAX.U	New York Stock Exchange
Class A ordinary shares, par value $0.0001 per share	AJAX	New York Stock Exchange
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50	AJAX WS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐	Large accelerated filer	☐	Accelerated filer
☒	Non-accelerated filer	☒	Smaller reporting company
		☒	Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☒ No ☐

As of ~~May 17~~August 12, 2021, there were 80,499,090 Class A ordinary shares, $0.0001 par value per share, and 8,944,343 Class B ordinary shares, $0.0001 par value per share, issued and outstanding respectively.

AJAX I

FORM 10-Q FOR THE QUARTER ENDED ~~MARCH~~JUNE 3130, 2021

TABLE OF CONTENTS

			Page
Part I. Financial Information
	Item 1. Financial Statements
		Condensed Balance Sheet	1
		Condensed Balance Sheets as of June 30, 2021 (unaudited) and December 31, 2020	1
		Condensed Statement of Operations	2
		Condensed Statements of Operations for the three and six months ended June 30, 2021 (unaudited)	2
		Condensed Statement of Changes in Shareholder’s Equity	3
		Condensed Statement of Changes in Shareholder’s Equity for the three and six months ended June 30, 2021 (unaudited)	3
		Condensed Statement of Cash Flows	4
		Condensed Statement of Cash Flows for the six months ended June 30, 2021 (unaudited)	4
		Notes to Unaudited Condensed Financial Statements	5
	Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		19
	Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk		23
	Item 4. Controls and Procedures		23
Part II. Other Information
	Item 1. Legal Proceedings		24
	Item 1A. Risk Factors		24
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		24
	Item 3. Defaults Upon Senior Securities		24
	Item 4. Mine Safety Disclosures		24
	Item 5. Other Information		24
	Item 6. Exhibits		25
Part III. Signatures			26

AJAX I

CONDENSED BALANCE ~~SHEET~~SHEETS

	March 31, 2021			December 31, 2020
	June 30, 2021			December 31, 2020
	Unaudited
ASSETS
Cash	$	~~361~~1,~~517~~916,741		$	633,355
Prepaid expenses		2,~~864~~418,~~441~~650			3,331,178
Total current assets		34,~~225~~335,~~958~~391			3,964,533
Cash and marketable securities held in Trust Account		805,~~241~~244,~~779~~565			805,100,267
TOTAL ASSETS	$	~~808~~809,~~467~~579,~~737~~956		$	809,064,800
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities – accrued expenses	$	2,~~299~~915,~~585~~951		$	91,069
Warrant Liability		82,398,148			155,599,680
Executive Loans		3,500,000			—
Warrant Liability		91,303,062			155,599,680
Deferred underwriting fee payable		28,174,682			28,174,682
Total Liabilities		~~112~~125,~~872~~893,~~415~~695			183,865,431
Commitments
Class A ordinary shares subject to possible redemption, 69,038,016 and 62,011,512 shares at redemption value at March 31, 2021 and December 31, 2020, respectively.		690,595,321			620,199,367
Class A ordinary shares subject to possible redemption, 80,499,090 and 62,011,512 shares at redemption value at June 30, 2021 and December 31, 2020, respectively.		805,244,565			620,199,367
Shareholders’ Equity
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding		—			—
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 11,461,074 and 18,487,578 shares issued and outstanding (excluding 69,038,016 and 62,011,512 shares subject to possible redemption) as of March 31, 2021 and December 31, 2020, respectively.		1,146			1,849
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 0 and 18,487,578 shares issued and outstanding (excluding 80,499,090 and 62,011,512 shares subject to possible redemption) as of June 30, 2021 and December 31, 2020, respectively.		—			1,849
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 8,944,343 shares issued and outstanding at March 31, 2021 and December 31, 2020		894			894
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 8,944,343 shares issued and outstanding at June 30, 2021 and December 31, 2020		894			894
Additional paid-in capital		~~47,671,874~~—			118,067,125
Accumulated deficit		(42121,~~673~~559,~~913~~198	)		(113,069,866	)
Total Shareholders’ Equity		5(121,~~000~~558,~~001~~304	)		5,000,002
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	~~808~~809,~~467~~579,~~737~~956		$	809,064,800

The accompanying notes are an integral part of the unaudited condensed financial statements.

AJAX I

CONDENSED ~~STATEMENT~~ STATEMENTS OF OPERATIONS

FOR THE THREE MONTHS ENDED MARCH 31, 2021

(Unaudited)

Formation and operating costs	$	2,947,137
	Three Months Ended June 30,			Six Months Ended June 30,
Loss from operations		(2,947,137	)
	2021			2021
Other income:
General and administrative expenses	$	3,006,974		$	5,954,111
Interest income – bank		46
Loss from operations		(3,006,974	)		(5,954,111	)
Interest earned on marketable securities held in Trust Account		113,935
Other income (expense):
Unrealized gain on marketable securities held in Trust Account		27,577
Interest earned on marketable securities held in Trust Account		42,956			156,937
Change in fair value of derivative liability		73,201,532
Unrealized gain (loss) on marketable securities held in Trust Account		(40,129	)		(12,552	)
Other income, net		73,343,090
Change in fair value of derivative liability		(8,904,914	)		64,296,618
Net income	$	70,395,953
Other income (expense), net		(8,902,087	)		64,441,003
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption		62,011,512
Net (loss) income	$	(11,909,061	)	$	58,486,892
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption	$	0.00
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to redemption		69,038,016			65,544,174
Basic weighted average shares outstanding, Non-redeemable ordinary shares		27,431,921
Basic and diluted net income per share, Class A ordinary shares subject to redemption	$	0.00		$	0.89
Basic net income per share, Non-redeemable ordinary shares	$	2.56
Basic and diluted weighted average shares outstanding, Non-redeemable ordinary shares		20,405,417			23,899,259
Diluted weighted average shares outstanding, Non-redeemable ordinary shares		28,857,958
Basic and diluted net income (loss) per share, Non-redeemable ordinary shares	$	(0.58	)	$	2.44
Diluted net loss per share, Non-redeemable ordinary shares	$	(0.11	)

The accompanying notes are an integral part of the unaudited condensed financial statements.

AJAX I

CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY

FOR THE THREE AND SIX MONTHS ENDED ~~MARCH~~JUNE 3130, 2021

(Unaudited)

	Class A Ordinary Shares						Class B Ordinary Shares				Additional Paid-in			Accumulated			Total Shareholders’
	Shares			Amount			Shares		Amount		Capital			Deficit			Equity
Balance — January 1, 2021		18,487,578		$	1,849			8,944,343	$	894	$	118,067,125		$	(113,069,866	)	$	5,000,002
Change in value of Class A ordinary shares subject to redemption		(7,026,504	)		(703	)		—		—		(70,395,251	)		—			(70,395,954	)
Net income		—			—			—		—		—			70,395,953			70,395,953
Balance – March 31, 2021		11,461,074		$	1,146			8,944,343	$	894	$	47,671,874		$	(42,673,913	)	$	5,000,001
Change in value of Class A ordinary shares subject to redemption		(11,461,074	)		(1,146	)		—		—		(47,671,874	)		(66,976,224	)		(114,649,244	)
Net loss		—			—			—		—		—			(11,909,061	)		(11,909,061	)
Balance – June 30, 2021		—			—			8,944,343	$	894		—			(121,559,198	)		(121,558,304	)

The accompanying notes are an integral part of the unaudited condensed financial statements.

AJAX I

CONDENSED STATEMENT OF CASH FLOWS

FOR THE ~~THREE~~SIX MONTHS ENDED ~~MARCH~~JUNE 3130, 2021

(Unaudited)

Cash Flows from Operating Activities:
Net income	$	7058,~~395~~486,~~953~~892
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account		(~~113~~156,~~935~~850	)
Unrealized gain on marketable securities held in Trust Account		~~(27~~12,~~577~~552	)
Change in fair value of warrant liability		(7364,~~201~~296,~~532~~618	)
Changes in operating assets and liabilities:
Prepaid expenses		~~466~~912,~~737~~528
Accrued expenses		2,~~208~~824,~~516~~882
Net cash used in operating activities		(~~271~~2,~~838~~216,614	)
Net Change in Cash		(271,838	)
Cash Flows from Financing Activities:
Proceeds from Executive Loans		3,500,000
Net cash provided by financing activities		3,500,000
Net Change in Cash		1,283,386
Cash – Beginning		633,355
Cash – Ending	$	~~361~~1,~~517~~916,741
Non-cash investing and financing activities:
Change in value of Class A ordinary shares subject to possible redemption	$	70185,~~395~~045,~~954~~198

The accompanying notes are an integral part of the unaudited condensed financial statements.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Ajax I (“Ajax” or the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on August 13, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”).

The Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of ~~March~~June 3130, 2021, the Company had not commenced any operations. All activity for the period from August 13, 2020 (inception) through ~~March~~June 3130, 2021, relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

The registration statement for the Company’s Initial Public Offering was declared effective on October 27, 2020. On October 30, 2020, the Company consummated the Initial Public Offering of 80,499,090 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), which includes the partial exercise by the underwriter of its over-allotment option in the amount of 5,499,090 Units, at an offering price of $10.00 per Unit, generating gross proceeds of $804,990,900 which is described in Note 3.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 21,129,818 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Ajax I Holdings, LLC (the “Sponsor”), generating gross proceeds of $21,129,818, which is described in Note 4.

Transaction costs amounted to $44,919,371, consisting of $16,099,818 of underwriting fees, $28,174,682 of deferred underwriting fees and $644,871 of other offering costs. These costs were charged to shareholders’ equity upon the completion of the Initial Public Offering. ~~In addition, at October 30, 2020, cash of $4,702,774 was held outside of the Trust Account (as defined below) and is available for the payment of offering expenses and for working capital purposes.~~

Following the closing of the Initial Public Offering on October 30, 2020, an amount of $804,990,900 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and certain of the proceeds of the sale of the Private Placement Warrants were placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete a Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding any deferred underwriting commissions held in the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

The Company will provide its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve a Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount held in the Trust Account (initially $10.00 per ordinary share), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such completion of a Business Combination and, if the Company seeks shareholder approval in connection with a Business Combination, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who vote at a general meeting of the Company. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination and to waive its redemption rights with respect to any such shares in connection with a shareholder vote to approve a Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. Additionally, each public shareholder may elect to redeem its Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.

Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.

The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment and (iii) to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination.

The Company will have until October 30, 2022 (the “Combination Period”) to complete a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a third party for services rendered or products sold to the Company, or by a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of trust assets, in each case net of the amount of interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Liquidity and Capital Resources

As of ~~March~~June 3130, 2021, the Company had $~~361~~1,~~517~~916,741 in its operating bank accounts and working ~~capital~~deficit of $~~926~~2,~~373~~080,560. InOn ~~order~~March to22, ~~finance~~2021, Daniel Och, our chief executive officer and chairman ~~transaction~~of ~~costs~~the inboard ~~connection~~of directors, committed to provide us with aan ~~Business~~aggregate ~~Combination~~of $1,500,000 in loans. On May 15, 2021, Daniel Och and Glenn Fuhrman, the ~~Sponsor~~Company’s orfounders, committed to provide us with an ~~affiliate~~aggregate of ~~the~~$2,000,000 ~~Sponsor~~in loans. On August 4, or2021, ~~certain~~Daniel ofOch and Glenn Fuhrman, the Company’s ~~officers~~ ~~and~~founders, ~~directors~~committed ~~may~~to provide us with an aggregate of $1,650,000 ~~but~~in loans. The loans are non-interest bearing, unsecured and will be repaid upon the consummation of a Business Combination. If the Company does not ~~obligated~~consummate toa Business Combination, all ~~provide~~amounts loaned to the Company ~~Working~~will ~~Capital~~be ~~Loans~~forgiven ~~(see~~except ~~Note~~to 6)the extent that the Company has funds available outside of the Trust Account to repay such loans. As of ~~March~~June 3130, 2021, there were no$3,500,000 ~~amounts~~Executive ~~outstanding~~Loans ~~under any Working Capital Loan~~outstanding.

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 6). As of June 30, 2021, there were no amounts outstanding under the Working Capital Loans.

The Company may raise additional capital through loans or additional investments from the Sponsor or its stockholders, officers, directors, or third parties. The Company’s officers and directors and the Sponsor may but are not obligated to (except as described above), loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Based on the foregoing, the Company believes it will have sufficient cash to meet its needs through the earlier of the consummation of a Business Combination or at least one year from the date that the financial statements were issued.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Amended and Restated Annual Report on Form 10-K/A for the period ended December 31, 2020 filed with the SEC on May 7, 2021. The operating results for the three and six months ended ~~March~~June 3130, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of ~~March~~June 3130, 2021 and December 31, 2020.

Marketable Securities Held in Trust Account

The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization or accretion of premiums or discounts.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at ~~March~~June 3130, 2021 and December 31, 692020,~~038~~ 80,~~016~~499,090 and 62,011,512 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance ~~sheet~~ sheets, respectively.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary shares are affected by charges against additional paid in capital and accumulated deficit.

Warrant Liability

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company accounts for the warrants issued in connection with our Initial Public Offering in accordance with the guidance contained in ASC 815-40-15-7D, under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The fair value of the Public Warrants initially was estimated using a Monte Carlo simulation approach (see Note 109). The fair value of the Private Placement Warrants initially was estimated using a Black-Scholes-Merton approach (see Note 109).

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of ~~March~~June 3130, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.

Net Income (Loss) per Ordinary Share

Net income (loss) per ordinary share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase 41,254,591 shares of Class A common stock in the calculation of diluted income per share, since the average stock price of the Company’s common stock for the three and six months ended June 30, 2021 was less than the exercise price and therefore, the inclusion of such warrants under the treasury stock method would be anti-dilutive.

The Company’s statement of operations includes a presentation of income (loss) per Class A ordinary share subject to possible redemption in a manner similar to the two-class method of income (loss) per ordinary share. Net income (loss) per Class A ordinary share, basic and diluted, for Class A ordinary shares subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account by the weighted average number of Class A ordinary shares subject to possible redemption outstanding for the three months ended ~~March~~June 3130, 2021.

Net loss per ordinary share, basic and diluted, for non-redeemable ordinary shares is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Class A ordinary shares subject to possible redemption, by the weighted average number of non-redeemable ordinary shares outstanding for the period.

Non-redeemable ordinary shares includes Class B ordinary shares and non-redeemable Class A ordinary shares as these ordinary shares do not have any redemption features. Non-redeemable ordinary shares participate in the income or loss on marketable securities based on Class A non-redeemable ordinary share’s proportionate interest.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):

	For the Three Months ended March 31, 2021
	Three Months Ended June 30, 2021			Six Months Ended June 30, 2021
Class A Ordinary shares subject to possible redemption
Numerator: Earnings allocable to Class A Ordinary shares subject to possible redemption
Interest earned on marketable securities held in Trust Account	$	9736,~~711~~169		$	132,193
Unrealized gain on marketable securities held in Trust Account		23(33,~~650~~821	)		(10,579	)
Net Income allocable to shares subject to redemption	$	~~121~~2,~~361~~348		$	121,614
Denominator: Weighted Average Class A ordinary shares subject to possible redemption
Basic and diluted weighted average shares outstanding		6269,~~011~~038,~~512~~016			65,544,174
Basic and diluted net income per share	$	~~0.00~~—		$	—
Non-Redeemable Ordinary Shares
Numerator: Net income minus Net Earnings- Basic
Numerator: Net Loss minus Net Earnings
Net income	$	70,395,953
Net (loss) income	$	(11,909,061	)	$	58,486,892
Less: Net income allocable to Class A ordinary shares subject to possible redemption		~~121~~(2,~~361~~348	)		(121,614	)
Non-Redeemable Net Income - Basic	$	70,274,592
Non-Redeemable Net (Loss) Income- Basic	$	(11,911,409	)	$	58,365,278
Denominator: Weighted Average Non-Redeemable ordinary shares
Denominator: Weighted Average Non-redeemable ordinary shares
Basic weighted average shares outstanding, Non-Redeemable ordinary shares		27,431,921
Basic and diluted weighted average shares outstanding, Non-Redeemable ordinary shares		20,405,417			23,899,259
Basic net income per share, Non-Redeemable ordinary shares	$	2.56
Basic and diluted net (loss) income per share, Non-Redeemable ordinary shares	$	(0.58	)	$	2.44
Numerator: Net income minus Net Earnings- Diluted
Non-Redeemable Net income - Basic	$	70,274,592
Less: Change in fair value of derivative liability		73,201,532
Non-Redeemable Net loss - Diluted	$	(2,926,940	)
Denominator: Weighted Average Non-Redeemable ordinary shares
Diluted weighted average shares outstanding, Non-Redeemable ordinary shares (1)		27,857,958
Diluted net loss per share, Non-Redeemable ordinary shares	$	(0.11	)

(1) Diluted weighted average shares outstanding was calculated using the treasury stock method utilizing a weighted average share price of $11.62 and the effect of the warrants sold in the Initial Public Offering and the private placement to purchase an aggregate of 41,254,590 shares.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed balance sheet, primarily due to their short-term nature.

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

NOTE 3. INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 80,499,090 Units, which includes a partial exercise by the underwriters of their over-allotment option in the amount of 5,499,090 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-fourth of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7).

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 21,129,818 Private Placement Warrants at a price of $1.00 per Private Placement Warrant (for an aggregate purchase price of $21,129,818), which includes a partial exercise by the underwriters of their over-allotment option in the amount of 1,099,818 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant (for an aggregate purchase price of $1,099,818). Each whole Private Placement Warrant is exercisable for one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7). The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On September 16, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 8,855,000 Class B ordinary shares (the “Founder Shares”). On September 22, 2020, the Company effected a share capitalization resulting in an aggregate of 9,583,333 Founder Shares being outstanding. The Founder Shares included an aggregate of up to 1,250,000 shares subject to forfeiture by the Sponsor so that the number of Founder Shares will collectively represent 10% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. As a result of the underwriters’ election to partially exercise their over-allotment option on October 30, 2020, a total of 611,010 Founder Shares are no longer subject to forfeiture and 638,990 shares were forfeited.

The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) two years after the completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.

Administrative Services Agreement

The Company entered into an agreement, commencing on October 27, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay the Sponsor a total of up to $10,000 per month for office space and administrative support services. For the three and six months ended ~~March 31~~June 30, 2021, the Company incurred and paid $30,000 and $60,000 in fees for these services, respectively.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

Promissory Note — Related Party

On September 16, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $500,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) June 30, 2021, or (i) the consummation of the Initial Public Offering. As of ~~March~~June 3130, 2021, there was ~~$275,000~~no outstanding balance under the Promissory Note. The outstanding balance under the Promissory Note of $500,000 was repaid at the closing of the Initial Public Offering on October 30, 2020.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of June 30, 2021 and December 31, 2020 there were no Working Capital Loans outstanding.

~~NOTE 6.~~Executive ~~COMMITMENTS~~Loan

On March 22, 2021, Daniel Och, our chief executive officer and chairman of the board of directors, committed to provide us with an aggregate of $1,500,000 in loans. On May 15, 2021, Daniel Och and Glenn Fuhrman, the Company’s founders, committed to provide us with an aggregate of $2,000,000 in loans. On August 4, 2021, Daniel Och and Glenn Fuhrman, committed to provide us with an aggregate of $1,650,000 in loans. The loans are non-interest bearing, unsecured and will be repaid upon the consummation of a Business Combination. If the Company does not consummate a Business Combination, all amounts loaned to the Company will be forgiven except to the extent that the Company has funds available outside of the Trust Account to repay such loans. As of June 30, 2021 there were $3,500,000 Executive Loans outstanding.

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration and Shareholder Rights

Pursuant to a registration rights agreement entered into on October 27, 2020, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to our Class A ordinary shares). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $28,174,682 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

~~Executive Loan~~Cazoo Business Combination Agreement

On March 22, 2021, Daniel Och, our chief executive officer and chairman of the board of directors, committed to provide us with an aggregate of $1,500,000 in loans. The loans, if issued, will be non-interest bearing, unsecured and will be repaid upon the consummation of a Business Combination. If the Company does not consummate a Business Combination, all amounts loaned to the Company will be forgiven except to the extent that we have funds available outside of the Trust Account to repay such loans.

Business Combination

On March 29, 2021, the Company entered into a business combination agreement (the “Cazoo Business Combination Agreement”) with Cazoo Holdings Limited, a private limited company formed under the laws of England and Wales (the “Cazoo”), and Capri Listco, a Cayman Islands exempted company (“Listco”). The transactions contemplated by the Cazoo Business Combination Agreement are referred to herein as the “Cazoo Business Combination.” The board of directors of the Company and a committee of the board of directors of the Cazoo unanimously approved the Cazoo Business Combination.

The Cazoo Business Combination Agreement provides, subject to the terms and conditions therein, for the consummation of, among other things, the following transactions prior to the closing of the Cazoo Business Combination (collectively, the “Reorganization”): (a) approximately three business days prior to the closing of the Cazoo Business Combination (the “Listco Closing Date”), the sole shareholder of Listco will transfer to the Company all of the issued and outstanding equity securities of Listco and, as a result of such transfer, Listco shall become a wholly-owned subsidiary of the Company, and (b) following the Listco Closing Date, the Company will be merged with and into Listco, with Listco continuing as the surviving entity (the “Merger”). In connection with the Merger, each Unit, Class A ordinary share, Class B ordinary share and warrant issued and outstanding immediately prior to the Merger will be cancelled in exchange for the right to receive one Listco unit (consisting of one Listco Class A Share and one-fourth of one redeemable Listco warrant) (the “Listco Units”), Class A ordinary share, par value $0.0001 per share (the “Listco Class A Shares”), Class B ordinary share, par value $0.0001 per share (the “Listco Class B Shares”), and warrant to purchase Listco Class A ordinary shares, respectively.

Approximately two days following the completion of the Reorganization and at the closing of the Cazoo Business Combination (the “Closing”), pursuant to the Cazoo Business Combination Agreement, subject to the terms and conditions therein, Listco will acquire all of the issued and outstanding shares of the Cazoo from the holders thereof (the “Cazoo Shareholders”). Cazoo Shareholders will, subject to the procedures, limitations and rationing mechanics set forth in the Cazoo Business Combination Agreement, have the ability to elect the mix of cash and Listco Class C ordinary shares, par value $0.0001 per share (the “Listco Class C Shares”) each such Cazoo Shareholder will receive. The Listco Class C Shares will, subject to certain exceptions, be non-transferrable for 180 days following the Closing, at which time, such Listco Class C Shares will automatically convert into Listco Class A Shares in accordance with Listco’s governing documents. Additionally, effective as of the Closing, (a) the issued and outstanding Listco Class B Shares will convert automatically on a one-for-one basis into Listco Class A Shares, and (b) each issued and outstanding Listco Unit will automatically separate into its component parts.

The Cazoo Business Combination will be consummated subject to the deliverables and provisions as further described in the Cazoo Business Combination Agreement.

On March 29, 2021, concurrently with the execution of the Cazoo Business Combination Agreement, the Company and Listco entered into subscription agreements (collectively, the “Subscription Agreements”) with certain investors (the “PIPE Investors”) pursuant to which, among other things, the PIPE Investors have agreed to subscribe for and purchase, and Listco has agreed to issue and sell to the PIPE Investors, an aggregate of 80,000,000 Listco Class A Shares for an aggregate purchase price of $800,000,000 concurrently with the Closing, on the terms and subject to the conditions set forth therein. The Subscription Agreements contain customary representations and warranties of the Company and Listco, on the one hand, and each PIPE Investor, on the other hand, and customary conditions to closing, including the consummation of the transactions contemplated by the Cazoo Business Combination Agreement. The securities that may be issued in connection with the Subscription Agreements will not be registered under the Securities Act, and will be issued in reliance on the exemption from registration requirements thereof provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.

Legal Update

On June 3, 2021, June 8, 2021, July 13, 2021, July 27, 2021, August 6, 2021 and August 10, 2021, respectively, the Company received six demand letters from purported shareholders of the Company claiming certain alleged material omissions in the definitive proxy statement/prospectus, initially filed with the SEC on May 14, 2021, surrounding its planned transaction with Cazoo. A complaint asserting similar claims was filed on August 2, 2021 on behalf of one of these purported shareholders in the Supreme Court of the State of New York, County of New York: Ben Hoftyzer v. Ajax I, et al., Index No. 654725/2021. This complaint was later dismissed voluntarily by the plaintiff on August 12, 2021. Other, similar suits may follow. The Company specifically denies all allegations in the complaint and demand letters that any additional disclosure was or is required and believes these purported shareholders’ claims are without merit.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

NOTE 7. SHAREHOLDERS’ EQUITY

Preference Shares — The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At ~~March~~June 3130, 2021 and December 31, 2020, there were no preference shares issued or outstanding.

Class A Ordinary Shares — The Company is authorized to issue 500,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At ~~March~~June 3130, 2021 and December 31, 2020, there ~~was~~were ~~11,461,074~~0 and 18,487,578 shares, respectively, of Class A ordinary shares issued and outstanding, excluding 69 80,~~038~~499,~~016~~090 and 62,011,512 shares, respectively, of Class A ordinary shares subject to possible redemption.

~~Class B Ordinary Shares —~~ The Company isdetermined ~~authorized~~the toordinary ~~issue~~shares ~~50,000,000~~subject to ~~Class~~redemption Bto ~~ordinary~~be ~~shares,~~equal ~~with~~to athe ~~par~~redemption value of approximately $010.~~0001~~ 00 per share. ~~Holders~~ of ~~the~~common ~~Class~~stock Bwhile ~~ordinary~~also ~~shares~~taking ~~are~~into ~~entitled~~consideration a toredemption ~~one~~cannot ~~vote~~result ~~for~~in ~~each~~net ~~share.~~tangible Atassets ~~March~~being 31less than $5,000,001. ~~2021~~Upon considering the impact of the PIPE Investment and ~~December~~associated PIPE 31Subscription Agreements, it was concluded that the redemption value should include all the Public Shares resulting in the ordinary ~~2020,~~shares ~~there~~subject ~~were~~to 8possible redemption being equal to $805,~~944~~244,~~343~~565. ~~Class~~This Bresulted in a measurement adjustment to the initial carrying value of the ordinary shares ~~issued~~subject to redemption with the offset recorded to additional paid-in capital and ~~outstanding~~accumulated deficit.

Class B Ordinary Shares — The Company is authorized to issue 50,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share. At June 30, 2021 and December 31, 2020, there were 8,944,343 Class B ordinary shares issued and outstanding.

Only holders of the Class B ordinary shares will have the right to vote on the election of directors prior to the Cazoo Business Combination. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of the Company’s shareholders except as otherwise required by law.

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which the Class B ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 10% of the sum of all ordinary shares issued and outstanding upon the completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with a Business Combination, excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination.

NOTE 8. WARRANTS

Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years from the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating thereto is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, it will use its commercially reasonable efforts to file with the SEC a registration statement covering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of a Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Class A ordinary shares are, at the time of any exercise of a warrant, not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 — Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:

	●	in whole and not in part;

	●	at a price of $0.01 per Public Warrant;

	●	upon not less than 30 days’ prior written notice of redemption to each warrant holder and

	●	if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “ Reference Value”) equals or exceeds $18.00 per share (as adjusted).

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 — Once the warrants become exercisable, the Company may redeem the outstanding warrants:

	●	in whole and not in part;

	●	at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Class A ordinary shares; and

	●	if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted).

The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company; (2) they (including the ordinary shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of a Business Combination; (3) they may be exercised by the holders on a cashless basis; (4) they (including the ordinary shares issuable upon exercise of these warrants) are entitled to registration rights; and (5) they can only be exercised during the period (A) commencing on the later of: (i) the date that is thirty (30) days after the first date on which the Company completes its Business Combination, and (ii) the date that is twelve (12) months from the date of the closing of the Initial Public Offering, and (B) terminating at the earliest to occur of (x) 5:00 p.m., New York City time on the date that is seven years after the date on which the Company completes its Business Combination, and (y) the liquidation of the Company in accordance with the Company’s Amended and Restated Memorandum and Articles of Association, as amended from time to time, if the Company fails to complete a Business Combination.

NOTE 9. FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC Topic 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1:

Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2:

Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Level 3:

Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

AJAX I I NOTES TO CONDENSED FINANCIAL STATEMENTS ~~MARCH~~JUNE 3130, 2021 (Unaudited)

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at ~~March~~June 3130, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Description	Level	June 30, 2021	~~March 31, 2021~~		December 31, 2020	~~December 31, 2020~~
Assets:
Marketable securities held in Trust Account	1	$	$805,244,565	~~805,241,779~~	$	$805,100,267	~~805,100,267~~
Liabilities
Warrant Liability – Public Warrants	1	$	$37,633,324	~~34,010,865~~	$	$66,009,252	~~66,009,252~~
Warrant Liability – Private Warrants	3	$	$53,669,738	~~48,387,283~~	$	$89,590,428	~~89,590,428~~

The warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the accompanying balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within the change in fair value of warrant liabilities in the statement of operations.

Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.

The fair value of the Private Placement Warrants was estimated at ~~March~~June 3130, 2021 and December 31, 2020 to be $2.2954 and $4.24, respectively, using the modified Black-Scholes option pricing model and the following assumptions:

	March 31, 2021			December 31, 2020
	June 30, 2021			December 31, 2020
Expected volatility		2026.84	%		30.6	%
Risk-free interest rate		1.4622	%		0.73	%
Expected term (years)		7.5700			7.82
Fair value per share of Class A ordinary shares	$	109.2696		$	11.80

The following table presents the changes in the fair value of warrant liabilities:

	Private Placement			Public			Warrant Liabilities
	Private Placement			Public			Warrant Liabilities
Fair value as of January 1, 2021	$	89,590,428		$	66,009,252		$	155,599,680
Fair value as of December 31, 2020	$	89,590,428		$	66,009,252		$	155,599,680
Change in valuation inputs or other assumptions		(4135,~~203~~920,~~145~~690	)		(3128,~~998~~375,~~387~~928	)		(7364,~~201~~296,~~532~~618	)
Fair value as of March 31, 2021	$	48,387,283		$	34,010,865		$	82,398,148
Fair value as of June 30, 2021	$	53,669,738		$	37,633,324		$	91,303,062

There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three and six months ended ~~March~~June 3130, 2021.

NOTE 10. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

On ~~May~~August 154, 2021, Daniel Och and Glenn Fuhrman, the Company’s founders, committed to provide usthe Company with an aggregate of $21,~~000~~650,000 in loans. The loans, if issued, will be non-interest bearing, unsecured and will be repaid upon the consummation of a Business Combination. If the Company does not consummate a Business Combination, all amounts loaned to the Company will be forgiven except to the extent that we have funds available outside of the Trust Account to repay such loans.

Stockholder Litigation and Demands

On June 3, 2021, June 8, 2021, July 13, 2021, July 27, 2021, August 6, 2021 and August 10, 2021, respectively, the Company received six demand letters from purported shareholders of the Company claiming certain alleged material omissions in the definitive proxy statement/prospectus, initially filed with the SEC on May 14, 2021, surrounding its planned transaction with Cazoo. A complaint asserting similar claims was filed on August 2, 2021 on behalf of one of these purported shareholders in the Supreme Court of the State of New York, County of New York: Ben Hoftyzer v. Ajax I, et al., Index No. 654725/2021. This complaint was later dismissed voluntarily by the plaintiff on August 12, 2021. Other, similar suits may follow. The Company specifically denies all allegations in the complaint and demand letters that any additional disclosure was or is required and believes these purported shareholders’ claims are without merit.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us,” “Ajax” or the “Company” refer to Ajax I. References to our “management” refer to our officers and directors, and references to the “Sponsor” refer to Ajax I Holdings, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from ~~the~~ the events, performance and results discussed in the forward-looking statements. For information identifying important factors that ~~could~~ could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Amended and Restated Annual Report on Form 10-K/A for the year ended December 31, 2020 filed with the ~~U.S. Securities and Exchange Commission (the “~~SEC”) on May 7, 2021. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated in the Cayman Islands on August 13, 2020 formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our shares, debt or a combination of cash, shares and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Recent Developments

On March 29, 2021, we entered into a business combination agreement (the “Cazoo Business Combination Agreement”) with Cazoo Holdings Limited, a private limited company formed under the laws of England and Wales (the “Cazoo”), and Capri Listco, a Cayman Islands exempted company (“Listco”). The transactions contemplated by the Cazoo Business Combination Agreement are referred to herein as the “Cazoo Business Combination.” Our board of directors and a committee of the board of directors of the Cazoo unanimously approved the Cazoo Business Combination.

The Cazoo Business Combination Agreement provides, subject to the terms and conditions therein, for the consummation of, among other things, the following transactions prior to the closing of the Cazoo Business Combination (collectively, the “Reorganization”): (a) approximately three business days prior to the closing of the Cazoo Business Combination (the “Listco Closing Date”), the sole shareholder of Listco will transfer to Ajax all of the issued and outstanding equity securities of Listco and, as a result of such transfer, Listco shall become a wholly-owned subsidiary of Ajax, and (b) following the Listco Closing Date, we will be merged with and into Listco, with Listco continuing as the surviving entity (the “Merger”). In connection with the Merger, each Unit, Class A ordinary share, Class B ordinary share and warrant issued and outstanding immediately prior to the Merger will be cancelled in exchange for the right to receive one Listco unit (consisting of one Listco Class A Share and one-fourth of one redeemable Listco warrant) (the “Listco Units”), Class A ordinary share, par value $0.0001 per share (the “Listco Class A Shares”), Class B ordinary share, par value $0.0001 per share (the “Listco Class B Shares”), and warrant to purchase Listco Class A ordinary shares, respectively.

The Cazoo Business Combination will be consummated subject to the deliverables and provisions as further described in the Cazoo Business Combination Agreement.

On March 29, 2021, concurrently with the execution of the Cazoo Business Combination Agreement, we and Listco entered into subscription agreements (collectively, the “Subscription Agreements”) with certain investors (the “PIPE Investors”) pursuant to which, among other things, the PIPE Investors have agreed to subscribe for and purchase, and Listco has agreed to issue and sell to the PIPE Investors, an aggregate of 80,000,000 Listco Class A Shares for an aggregate purchase price of $800,000,000 concurrently with the Closing, on the terms and subject to the conditions set forth therein.

For more information about the Cazoo Business Combination Agreement and the proposed Cazoo Business Combination, see our Current Report on Form 8-K filed with the SEC on March 29, 2021. Unless specifically stated, this Quarterly Report does not give effect to the proposed Cazoo Business Combination and does not contain the risks associated with the proposed Cazoo Business Combination.

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. Our only activities from for the three months ended ~~March~~June 3130, 2021 were organizational activities and those necessary to prepare for the Initial Public Offering, described below. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We expect to generate non-operating income in the form of interest income on marketable securities held after the Initial Public Offering. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

For the three months ended ~~March~~June 3130, 2021, we had net ~~income~~loss of $7011,~~395~~909,~~953~~061, which consisted of operating costs of $23,~~947~~006,~~137~~974 a non-cash change in fair value of derivative liability of $738,~~201~~904,~~532~~914, offset by interest income from operating bank account of $4641, interest income on marketable securities held in the Trust Account of $~~113~~42,~~935~~ 915 and an unrealized gain on marketable securities held in the Trust Account of $2740,~~577~~129.

~~Liquidity~~For the six months ended June 30, 2021, we had net income of $58,486,892, which consisted of a non-cash change in fair value of derivative liability of $64,296,618, interest income from operating bank account of $87 and ~~Capital~~interest ~~Resources~~income on marketable securities held in the Trust Account of $156,850, offset by operating costs of $5,954,111 and an unrealized gain on marketable securities held in the Trust Account of $12,552.

~~On October~~Liquidity ~~30,~~and ~~2020,~~Capital we consummated the Initial Public Offering of 80,499,090 Units, which included the partial exercise by the underwriters of their over-allotment option in the amount of 5,499,090 Units, at a price of $10.00 per Unit, generating gross proceeds of $804,990,900. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 21,129,818 Private Placement Warrants to the Sponsor at a price of $1.00 per Private Placement Warrant generating gross proceeds of $21,129,818.Resources

~~Following~~ On October 30, 2020, we consummated the Initial Public Offering ~~and~~of 80,499,090 Units, which included the ~~sale~~partial exercise by the underwriters of their over-allotment option in the ~~Private~~amount of ~~Placement~~5,499,090 ~~Warrants~~Units, at a ~~total~~price of $10.00 per Unit, generating gross proceeds of $804,990,900. ~~was~~Simultaneously ~~placed~~with in the ~~Trust~~closing ~~Account. We~~of ~~incurred~~the ~~$44~~Initial Public Offering,~~919,371~~ inwe ~~transaction~~consummated ~~costs,~~the ~~including~~sale ~~$16~~of 21,~~099~~129,818 ofPrivate ~~underwriting~~Placement ~~fees,~~Warrants ~~$28,174,682~~to the Sponsor at a price of ~~deferred~~$1.00 ~~underwriting~~per Private Placement ~~fees~~Warrant ~~and~~generating ~~$644,871~~gross proceeds of ~~other costs~~$21,129,818.

~~For~~ Following the ~~three~~Initial ~~months~~Public ~~ending~~Offering ~~March~~and ~~31,~~the sale ~~2021~~of ~~cash~~the ~~used~~Private inPlacement ~~operating activities was $271~~Warrants,~~838.~~ ~~Net~~a ~~income~~total of $70804,~~395~~990,~~953~~900 was ~~affected by~~placed ain ~~non-cash charges including~~ the ~~change~~Trust inAccount. ~~fair~~We ~~value~~incurred ~~of warrant liability of~~ $7344,~~201~~919,~~532,~~371 ~~interest~~in ~~earned on marketable securities~~transaction ~~held~~costs, inincluding ~~the Trust Account of~~ $~~113~~16,~~935~~099,818 ~~and~~of ~~unrealized~~underwriting ~~gain~~fees, ~~on marketable securities held in Trust Account~~ $2728,~~577.~~174,682 ~~Changes~~of indeferred ~~operating assets~~underwriting fees and ~~liabilities provided~~ $2644,~~675,253~~871 of ~~cash~~other ~~for operating activities~~costs.

20For the six months ending June 30, 2021 cash used in operating activities was $2,216,614. Net income of $58,486,892 was affected by a non-cash charges including the change in fair value of warrant liability of $64,296,618, interest earned on marketable securities held in the Trust Account of $156,850 and unrealized gain on marketable securities held in Trust Account $12,552. Changes in operating assets and liabilities provided $3,737,410 of cash for operating activities.

As of March 31, 2021, we had cash and marketable securities held in the Trust Account of $805,241,779. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, which interest shall be net of taxes payable and excluding deferred underwriting commissions, to complete our Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any. Through March 31, 2021, we did not withdraw any interest earned on the Trust Account to pay our taxes. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.20

As of ~~March~~June 3130, 2021, we had cash and marketable securities held in the Trust Account of $~~361~~805,~~517~~244,565. We intend to use substantially all of the funds held ~~outside~~in the Trust Account, ~~primarily~~including any toamounts ~~identify~~representing ~~and evaluate~~interest ~~target~~earned ~~businesses~~on the Trust Account, ~~perform~~which ~~business~~interest ~~due~~shall ~~diligence~~be onnet ~~prospective~~of ~~target~~taxes ~~businesses,~~payable ~~travel~~and excluding deferred underwriting commissions, to ~~and~~complete our Business Combination. We may withdraw interest from the ~~offices~~Trust Account to pay taxes, ~~plants~~if any. Through June or30, ~~similar~~2021, ~~locations~~we ofdid ~~prospective~~not ~~target~~withdraw ~~businesses~~any interest earned on the Trust Account to pay our taxes. To the extent that our share capital or ~~their~~debt is ~~representatives~~used, in whole or ~~owners~~in part, ~~review~~as ~~corporate~~consideration ~~documents~~to ~~and~~complete ~~material~~a Business Combination, the remaining proceeds held in the Trust Account will ~~agreements~~be used as working capital to finance the operations of ~~prospective~~the target business or businesses, ~~structure,~~make ~~negotiate~~other acquisitions and ~~complete~~pursue aour ~~Business Combination~~growth strategies.

InAs ~~March~~of ~~2021,~~June ~~Daniel Och~~30, ~~our chief executive officer and chairman of the board of directors~~2021, ~~committed~~we tohad ~~provide~~cash ~~us with an aggregate~~ of $1,~~500~~916,~~000 in loans~~741. We Onintend ~~May~~to ~~15,~~use ~~2021,~~the ~~Daniel Och~~funds ~~and~~held ~~Glenn~~outside ~~Fuhrman,~~the ~~our~~Trust ~~founders,~~Account ~~committed~~primarily to ~~provide~~identify usand ~~with~~evaluate antarget ~~aggregate of $2~~businesses,~~000,000~~ inperform ~~loans.~~business ~~The~~due ~~loans,~~diligence on ifprospective ~~issued,~~target ~~will be non-interest bearing~~businesses, ~~unsecured~~travel to and ~~will~~from ~~be repaid upon~~ the ~~consummation~~offices, ofplants aor ~~Business~~similar ~~Combination.~~locations Ifof ~~the~~prospective ~~Company~~target ~~does~~businesses ~~not~~or ~~consummate~~their representatives aor ~~Business Combination~~owners, ~~all~~ ~~amounts~~review ~~loaned~~corporate todocuments ~~the~~and ~~Company~~material ~~will~~agreements beof ~~forgiven~~prospective ~~except~~target tobusinesses, ~~the~~structure, ~~extent~~negotiate ~~that~~and complete wea ~~have~~Business ~~funds available outside of the Trust Account to repay such loans~~Combination.

In ~~order~~ toMarch ~~fund~~2021, ~~working~~Daniel ~~capital~~Och, ~~deficiencies~~our orchief ~~finance~~executive ~~transaction~~officer and ~~costs~~chairman inof ~~connection~~the ~~with~~board aof ~~Business Combination~~directors, ~~our~~committed ~~Sponsor or~~to anprovide ~~affiliate~~us ofwith ~~our~~an ~~Sponsor~~aggregate ~~or certain~~ of ~~our officers and directors may~~$1,500,000 ~~but~~in ~~are~~loans. ~~not~~On ~~obligated~~May to15, ~~loan~~2021, usDaniel ~~funds as may be~~Och ~~required.~~and IfGlenn weFuhrman, ~~complete~~our ~~a Business Combination~~founders, wecommitted ~~may~~to ~~repay~~provide ~~such~~us ~~loaned~~with ~~amounts~~an ~~out~~aggregate of ~~the~~$2,00,000 ~~proceeds~~in ofloans. ~~the~~On ~~Trust~~August ~~Account~~4, ~~released to~~2021, ~~us.~~Daniel InOch ~~the~~and ~~event~~Glenn Fuhrman, ~~that~~our afounders, ~~Business~~committed ~~Combination~~to ~~does~~provide ~~not~~us ~~close,~~with wean ~~may~~aggregate ~~use~~of a$1,650,000 ~~portion~~in ofloans. ~~the~~The ~~working~~loans ~~capital~~are ~~held~~non-interest ~~outside~~bearing, ~~the Trust~~unsecured ~~Account~~and towill ~~repay~~be ~~such~~repaid ~~loaned~~upon ~~amounts,~~the ~~but~~consummation noof ~~proceeds~~a ~~from~~Business ~~our~~Combination. ~~Trust~~If ~~Account~~we ~~would~~do benot ~~used~~consummate ~~for~~a ~~such~~Business ~~repayment.~~Combination, Upall toamounts ~~$2,500,000~~loaned ofto ~~such~~us ~~loans~~will ~~may~~ be ~~convertible~~forgiven ~~into~~except ~~warrants,~~to atthe aextent ~~price~~that ofwe ~~$1.00~~have ~~per~~funds ~~warrant,~~available atoutside ~~the option~~ of the ~~lender.~~Trust ~~The~~Account ~~warrants would be identical~~ to ~~the~~repay ~~Private~~such ~~Placement Warrants~~loans.

~~We do~~In ~~not~~order ~~believe~~to wefund ~~will~~working ~~need~~capital todeficiencies or ~~raise~~finance ~~additional~~transaction ~~funds~~costs in ~~order~~connection towith ~~meet~~a ~~the~~Business ~~expenditures~~Combination, ~~required~~our ~~for~~Sponsor ~~operating~~or ~~our~~an ~~business.~~affiliate ~~However, if~~of our ~~estimate~~Sponsor ofor ~~the~~certain ~~costs~~ of ~~identifying~~our aofficers and ~~target~~directors ~~business~~may, ~~undertaking~~but ~~in-depth~~are ~~due~~not ~~diligence~~obligated ~~and~~to, ~~negotiating~~loan aus ~~Business~~funds ~~Combination are~~as ~~less~~may ~~than~~be ~~the~~required. ~~actual~~If ~~amount~~we ~~necessary~~complete toa doBusiness soCombination, we may ~~have~~repay ~~insufficient~~such loaned ~~funds~~amounts ~~available~~out toof ~~operate~~the ~~our~~proceeds ~~business~~of ~~prior~~the Trust Account released to ~~our~~ ~~initial~~us. In the event that a Business Combination. ~~Moreover~~does not close, we may use ~~need~~a toportion ~~obtain~~of ~~additional~~the ~~financing~~working ~~either~~capital held outside the Trust Account to ~~complete~~repay such loaned amounts, but no proceeds from our ~~Business~~Trust ~~Combination~~Account orwould ~~because~~be weused ~~become~~for ~~obligated~~such repayment. Up to ~~redeem~~$2,500,000 aof ~~significant~~such ~~number~~loans ofmay ~~our~~be ~~public~~convertible ~~shares~~into ~~upon~~warrants, ~~completion~~at a price of ~~our~~$1.00 ~~Business~~per ~~Combination~~warrant, at inthe ~~which~~option ~~case~~of wethe ~~may~~lender. ~~issue~~The ~~additional~~warrants ~~securities~~would orbe ~~incur~~identical ~~debt~~to inthe ~~connection~~Private ~~with~~Placement ~~such Business Combination~~Warrants.

~~Off~~We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-~~Balance~~depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, ~~Sheet~~we ~~Financing~~may ~~Arrangements~~have insufficient funds available to operate our business prior to our initial Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

~~We have no obligations, assets or liabilities, which would be considered off~~Off-~~balance~~Balance ~~sheet~~Sheet ~~arrangements~~Financing as of March 31, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.Arrangements

~~Contractual~~We have no obligations, assets or liabilities, ~~Obligations~~which would be considered off-balance sheet arrangements as of June 30, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

~~We do~~Contractual not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor a monthly fee of $10,000 for office space administrative and support services provided to the Company. We began incurring these fees on October 27, 2020 and will continue to incur these fees monthly until the earlier of the completion of a Business Combination and the Company’s liquidation.Obligations

~~The underwriters~~We ~~are~~do ~~entitled~~not tohave aany ~~deferred~~long-term ~~fee~~debt, ofcapital ~~$0.35~~lease obligations, ~~per~~operating ~~Unit,~~lease obligations or ~~$28~~long-term liabilities,~~174,682~~ inother ~~the~~than ~~aggregate.~~an ~~The~~agreement ~~deferred~~to ~~fee~~pay ~~will~~the ~~become~~Sponsor ~~payable to~~a ~~the~~monthly ~~underwriters~~fee ~~from~~of ~~the~~$10,000 for ~~amounts~~office ~~held~~space inadministrative ~~the~~and ~~Trust~~support ~~Account~~services ~~solely~~provided into the ~~event~~Company. ~~that~~We webegan ~~complete~~incurring athese ~~Business~~fees ~~Combination~~on October 27, ~~subject~~2020 and will continue to incur these fees monthly until the ~~terms~~earlier of the ~~underwriting~~completion ~~agreement~~of a Business Combination and the Company’s liquidation.

21The underwriters are entitled to a deferred fee of $0.35 per Unit, or $28,174,682 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

~~Critical Accounting Policies~~21

~~The preparation~~Critical ofAccounting condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting policies.Policies

~~Class~~The preparation of condensed financial statements Aand ~~Ordinary~~related ~~Shares~~disclosures ~~Subject~~in conformity with accounting principles generally accepted in the United States of America requires management to ~~Redemption~~make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting policies.

~~We account for our~~ Class A ~~ordinary~~Ordinary ~~shares~~Shares ~~subject~~Subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of our balance sheet.Redemption

~~Warrant~~We account for our Class A ordinary shares subject ~~Liability~~to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of our balance sheet.

~~We account~~Warrant for the warrants issued in connection with our Initial Public Offering in accordance with the guidance contained in ASC 815-40-15-7D under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, we classify the warrants as liabilities and adjust the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised and any change in fair value is recognized in our statement of operations. The fair value of the warrants initially was estimated using a Monte Carlo simulation approach for the Public Warrants and a Black-Scholes-Merton model for the private placement warrants.Liability

~~Net~~We account for the warrants issued in connection ~~Loss~~with ~~Per~~our ~~Ordinary~~Initial ~~Share~~Public Offering in accordance with the guidance contained in ASC 815-40-15-7D under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, we classify the warrants as liabilities and adjust the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised and any change in fair value is recognized in our statement of operations. The fair value of the warrants initially was estimated using a Monte Carlo simulation approach for the Public Warrants and a Black-Scholes-Merton model for the private placement warrants.

Our statement of operations includes a presentation of income (loss) per share for Class A ordinary shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net ~~income~~Loss ~~per~~Per ~~ordinary~~Ordinary share, basic and diluted, for Class A ordinary shares subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account net of applicable taxes, if any, by the weighted average number of Class A ordinary shares subject to possible redemption outstanding for the three months ended March 31, 2021.Share

~~Net~~Our statement of operations includes a presentation of income (loss) per share for Class A ordinary shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net income per ordinary share, basic and diluted, for ~~non-redeemable~~Class A ordinary shares subject to possible redemption is calculated by dividing the ~~net~~proportionate ~~income~~share ~~(loss),~~of ~~adjusted for~~ income or loss on marketable securities ~~attributable~~held toby ~~Class~~the ATrust ~~ordinary~~Account ~~shares~~net ~~subject~~of toapplicable ~~possible redemption~~taxes, if any, by the weighted average number of ~~non-redeemable~~Class A ordinary shares subject to possible redemption outstanding for the ~~period~~three months ended June 30, 2021.

~~Non~~Net loss per share, basic and diluted, for non-redeemable ordinary shares ~~include~~is ~~Class~~calculated Bby ~~ordinary~~dividing ~~shares~~the ~~and~~net ~~non-redeemable~~income ~~Class~~(loss), Aadjusted ~~ordinary~~for ~~shares~~income asor ~~these~~loss ~~shares~~on domarketable ~~not~~securities ~~have~~attributable ~~any redemption~~to ~~features.~~Class ~~Non-redeemable~~A ordinary shares ~~participate~~subject into ~~the~~possible ~~income~~redemption, orby ~~loss~~the onweighted ~~marketable~~average ~~securities~~number ~~based~~of on non-redeemable ordinary shares’ outstanding for ~~proportionate~~the ~~interest~~period.

~~Recent~~Non-redeemable ordinary shares include Class B ~~Accounting~~ordinary ~~Pronouncements~~shares and non-redeemable Class A ordinary shares as these shares do not have any redemption features. Non-redeemable ordinary shares participate in the income or loss on marketable securities based on non-redeemable shares’ proportionate interest.

~~Management does~~Recent ~~not~~Accounting ~~believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.~~Pronouncements

22In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

~~ITEM~~Management does not believe that any other recently 3.issued, ~~QUANTITATIVE~~but ~~AND~~not ~~QUALITATIVE~~yet ~~DISCLOSURES~~effective, ~~ABOUT~~accounting ~~MARKET~~standards, ~~RISK~~if currently adopted, would have a material effect on our financial statements.

~~Not required for smaller reporting companies.~~22

ITEM 4 3. ~~CONTROLS~~QUANTITATIVE AND ~~PROCEDURES~~QUALITATIVE DISCLOSURES ABOUT MARKET RISK

~~Disclosure controls~~Not ~~and procedures are controls and other procedures that are designed to ensure that information~~ required tofor besmaller ~~disclosed in~~reporting ~~our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms~~companies. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

~~Evaluation of~~ITEM ~~Disclosure~~4. ~~Controls~~CONTROLS ~~and~~AND ~~Procedures~~PROCEDURES

AsDisclosure ~~required~~controls byand ~~Rules~~procedures ~~13a-15~~are controls and ~~15d-15~~other ~~under~~procedures ~~the~~that ~~Exchange~~are ~~Act,~~designed ~~our Chief~~to ~~Executive~~ensure ~~Officer~~that ~~and~~information ~~Chief~~required ~~Financial~~to ~~Officer~~be ~~carried~~disclosed ~~out~~in anour ~~evaluation~~reports offiled ~~the~~or ~~effectiveness~~submitted ofunder the Exchange ~~design~~Act ~~and~~is ~~operation~~recorded, ofprocessed, ~~our disclosure~~summarized ~~controls~~ and ~~procedures~~reported aswithin ofthe ~~March~~time ~~31,~~periods ~~2021.~~specified ~~Based~~in ~~upon~~the ~~their~~SEC’s ~~evaluation,~~rules ~~our~~and ~~Chief~~forms. ~~Executive~~Disclosure controls ~~Officer~~ and ~~Chief~~procedures ~~Financial Officer~~include, ~~concluded~~without ~~that~~limitation, ~~solely~~controls ~~due~~and toprocedures ~~the~~designed ~~Company’s~~to ~~restatement~~ensure ofthat ~~its~~information ~~financial~~required ~~statements~~ to ~~reclassify~~be ~~the~~disclosed in ~~Company’s~~our ~~Public~~reports ~~Warrants~~filed ~~and~~or ~~Private~~submitted ~~Placement~~under ~~Warrants~~the asExchange ~~described~~Act inis ~~the~~accumulated ~~Explanatory~~and ~~Note~~communicated to our ~~Form 10-K/A~~management, including our ~~disclosure~~Chief ~~controls~~Executive Officer and ~~procedures~~Chief ~~were~~Financial ~~not~~Officer, ~~effective~~to asallow oftimely ~~March~~decisions ~~31,~~regarding ~~2021~~required disclosure.

WeEvaluation ~~do not expect that our disclosure controls and procedures will prevent all errors and all instances~~ of ~~fraud.~~ Disclosure ~~controls~~Controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.Procedures

~~Restatement~~As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of ~~Previously~~ ~~Issued~~the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2021. Based upon their evaluation, our Chief Executive Officer and Chief Financial ~~Statements~~Officer concluded that, solely due to the Company’s restatement of its financial statements to reclassify the Company’s Public Warrants and Private Placement Warrants as described in the Explanatory Note to our Form 10-K/A, our disclosure controls and procedures were not effective as of June 30, 2021.

OnDisclosure ~~May~~controls 7,and ~~2021,~~procedures weare ~~revised~~designed to ensure that information required to be disclosed by us in our ~~prior~~Exchange ~~position~~Act onreports ~~accounting~~is ~~for~~recorded, ~~warrants~~processed, summarized, and reported within the time periods specified in the SEC’s rules and ~~concluded~~forms, and that such information is accumulated and communicated to our management, ~~previously~~including ~~issued~~our principal executive officer and principal financial ~~statements~~officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and ~~for~~procedures, ~~the~~no ~~period~~matter ~~from~~how ~~August~~well 13conceived and operated, ~~2020~~can ~~(inception)~~provide ~~through~~only ~~December~~reasonable, 31not absolute, ~~2020~~assurance ~~should~~that ~~not~~the beobjectives ~~relied~~of onthe ~~because~~disclosure controls and procedures are met. Further, the design of adisclosure ~~misapplication~~controls and inprocedures must reflect the ~~guidance~~fact onthat ~~warrant~~there ~~accounting.~~are ~~However~~resource constraints, and the ~~non-cash~~benefits ~~adjustments~~ must be considered relative to their costs. Because of the ~~financial~~inherent ~~statements~~limitations doin ~~not~~all ~~impact~~disclosure ~~the~~controls ~~amounts~~and ~~previously~~procedures, ~~reported~~no ~~for~~evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our ~~cash~~control deficiencies and ~~cash~~instances ~~equivalents~~of fraud, ~~total~~if ~~assets~~any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, ~~revenue~~and orthere can be no assurance ~~cash~~that ~~flows~~any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter cover by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting, as the circumstances that led to the restatement of our financial statements described in our Amended and Restated Annual Report on Form 10-K/A filed with the SEC on May 7, 2021 had not yet been identified. In light of the restatement of of our financial statements included in our Form 10-K/A, we plan to enhance our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

~~None.~~Stockholder Litigation and Demands

~~ITEM~~On 1AJune 3, 2021, June 8, 2021, July 13, 2021, July 27, 2021, August 6, 2021 and August 10, 2021, respectively, the Company received six demand letters from purported shareholders of the Company claiming certain alleged material omissions in the definitive proxy statement/prospectus, initially filed with the SEC on May 14, 2021, surrounding its planned transaction with Cazoo. ~~RISK~~A ~~FACTORS~~complaint was filed on August 2, 2021 on behalf of one of these purported shareholders in the Supreme Court of the State of New York, County of New York: Ben Hoftyzer v. Ajax I, et al., Index No. 654725/2021. This complaint was later dismissed voluntarily by the plaintiff on August 12, 2021. Other, similar suits may follow. The Company specifically denies all allegations in the complaint and demand letters that any additional disclosure was or is required and believes these purported shareholders’ claims are without merit.

~~Factors that~~ITEM ~~could cause our actual results to differ materially from those in this Quarterly Report on Form 10-Q are any of the risks described in Part I, Item~~ 1A~~, Risk Factors of our Amended and Restated Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on May 7, 2021~~. ~~Any~~RISK ~~of these factors could result in a significant or material adverse effect on our results of operations or financial condition~~FACTORS. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Amended and Restated Annual Report on Form 10-K for the year ended December 31, 2020.

~~ITEM~~Factors that could cause our actual results to 2differ materially from those in this Quarterly Report on Form 10-Q are any of the risks described in Part I, Item 1A, Risk Factors of our Amended and Restated Annual Report on Form 10-K/A for the year ended December 31, 2020 filed with the SEC on May 7, 2021. ~~UNREGISTERED~~Any ~~SALES~~of OFthese factors ~~EQUITY~~could ~~SECURITIES~~result ~~AND~~in ~~USE~~a OFsignificant ~~PROCEEDS~~or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Amended and Restated Annual Report on Form 10-K/A for the year ended December 31, 2020.

~~On October~~ITEM 30, 2020, we consummated our Initial Public Offering of 80,499,090 Units, inclusive of 5,499,090 Units sold to the underwriters upon the underwriters’ election to partially exercise their over-allotment option, at a price of $102.00 ~~per~~UNREGISTERED ~~Unit, generating~~SALES ~~total~~OF ~~gross~~EQUITY ~~proceeds~~SECURITIES ofAND ~~$804,990,900.~~USE ~~Goldman~~OF ~~Sachs & Co~~PROCEEDS. LLC, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC acted as the book-running managers. The securities sold in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-249411). The registration statement became effective on October 27, 2020.

~~Simultaneously with~~On ~~the~~October ~~consummation~~30, of2020, ~~the~~we ~~Initial~~consummated our Initial Public Offering, weof ~~consummated~~80,499,090 aUnits, ~~private~~inclusive ~~placement~~ of 215,~~129~~499,~~818~~090 ~~Private~~Units ~~Placement~~sold ~~Warrants~~ to ~~our~~the ~~Sponsor~~underwriters upon the underwriters’ election to partially exercise their over-allotment option, at a price of $110.00 per ~~Private Placement Warrant~~Unit, generating total gross proceeds of $21804,~~129~~990,~~818~~900. ~~Such~~Goldman ~~securities~~Sachs ~~were~~& ~~issued~~Co. ~~pursuant~~LLC, toCitigroup Global Markets Inc. and J.P. Morgan Securities LLC acted as the ~~exemption~~book-running ~~from~~managers. ~~registration~~The ~~contained~~securities sold in ~~Section~~the ~~4(a)(2)~~offering were ofregistered under the Securities Act on a registration statement on Form S-1 (No. 333-249411). The registration statement became effective on October 27, 2020.

~~The Private~~Simultaneously ~~Placement~~with ~~Warrants are identical to~~ the ~~Public~~consummation ~~Warrants~~of ~~underlying~~ the ~~Units sold in the~~ Initial Public Offering, ~~except that,~~we soconsummated ~~long~~a asprivate ~~they~~placement ~~are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company; (2) they (including the ordinary shares issuable upon exercise~~ of ~~these warrants) may not~~21, ~~subject to certain limited exceptions~~129, be818 ~~transferred,~~Private ~~assigned~~Placement orWarrants ~~sold~~to byour ~~the~~ Sponsor ~~until~~at ~~30 days after the completion of~~ a ~~Business~~price ~~Combination; (3) they may be exercised by the holders on a cashless basis; (4) they (including the ordinary shares issuable upon exercise~~ of ~~these~~$1.00 ~~warrants) are~~per ~~entitled to registration rights; and (5) they can only be exercised during the period (A) commencing on the later of: (i)~~Private ~~the~~Placement ~~date that is thirty (30) days after the first date on which the Company completes its Business Combination~~Warrant, ~~and~~generating ~~(ii)~~total ~~the~~proceeds ~~date that is twelve (12) months from the date~~ of ~~the closing of the Initial Public Offering~~$21,129,818. ~~and~~Such ~~(B)~~securities ~~terminating~~were atissued ~~the~~pursuant ~~earliest~~ to ~~occur~~ ~~of (x) 5:00 p.m., New York City time on~~ the ~~date~~exemption ~~that~~from isregistration ~~seven years after the date on which the Company completes its Business~~contained ~~Combination,~~in ~~and~~Section 4(ya)(2) ~~the liquidation~~ of the ~~Company~~Securities ~~in accordance with the Company’s Amended and Restated Memorandum and Articles of Association, as amended from time to time, if the Company fails to complete a Business Combination~~Act.

OfThe Private Placement Warrants are identical to the ~~gross~~Public ~~proceeds~~Warrants ~~received~~underlying ~~from~~the Units sold in the Initial Public Offering, except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company; (2) they (including the ~~over-allotment~~ordinary ~~option~~shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of a Business Combination; (3) they may be exercised by the holders on a cashless basis; (4) they (including the ordinary shares issuable upon exercise of these warrants) are entitled to registration rights; and (5) they can only be exercised during the ~~sale~~period (A) commencing on the later of: (i) the ~~Private~~date that is thirty (30) days after the first date on which the Company completes its Business ~~Placement~~Combination, ~~Warrants~~and (ii) the date that is twelve (12) months from the date of the closing of the Initial Public Offering, ~~$804~~and (B) terminating at the earliest to occur of (x) 5:00 p.m.,~~990~~ New York City time on the date that is seven years after the date on which the Company completes its Business Combination,~~900~~ ~~was~~and ~~placed~~(y) the liquidation of the Company in accordance with the ~~Trust~~Company’s ~~Account~~Amended and Restated Memorandum and Articles of Association, as amended from time to time, if the Company fails to complete a Business Combination.

~~We paid~~Of athe ~~total~~gross ofproceeds ~~$16,099,818~~received infrom ~~underwriting~~the ~~discounts~~Initial Public ~~and~~Offering ~~commissions~~including ~~and~~the ~~$644~~over-allotment option,~~871~~ ~~for other costs~~ and ~~expenses~~the ~~related~~sale toof the ~~Initial~~ ~~Public~~Private ~~Offering.~~Placement ~~In addition~~Warrants, ~~the underwriters agreed to defer~~ $28804,~~174~~990,~~682~~900 inwas ~~underwriting~~placed ~~discounts~~in ~~and~~the ~~commissions~~Trust Account.

~~For~~ We paid a ~~description~~total of ~~the~~$16,099,818 ~~use~~in ofunderwriting discounts ~~the~~and ~~proceeds~~commissions ~~generated~~and in$644,871 ~~our~~for other costs and expenses related to the Initial Public Offering. In addition, ~~see~~the ~~Part~~underwriters agreed I,to ~~Item~~defer 2$28,174,682 ofin ~~this~~underwriting ~~Form~~discounts ~~10-Q~~and commissions.

~~ITEM~~For a description of the use of the proceeds generated 3.in ~~DEFAULTS~~our ~~UPON~~Initial ~~SENIOR~~Public ~~SECURITIES~~Offering, see Part I, Item 2 of this Form 10-Q.

~~None~~ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

~~ITEM 4~~None. ~~MINE SAFETY DISCLOSURES.~~

~~Not applicable~~ITEM 4. MINE SAFETY DISCLOSURES.

~~ITEM 5.~~Not ~~OTHER INFORMATION~~applicable.

~~None~~ITEM 5. OTHER INFORMATION.

24None.

~~ITEM 6. EXHIBITS.~~24

~~The following~~ITEM ~~exhibits~~6. ~~are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q~~EXHIBITS.

No.		Description of Exhibit
1.1		Underwriting Agreement, dated October 27, 2020, between the Company, Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC. (2)
2.1		Business Combination Agreement, dated as of March 29, 2021, by and among Ajax I, Cazoo Holdings Limited and Capri Listco.(1)
3.1		Amended and Restated Memorandum and Articles of Association of the Company. (2)
4.1		Warrant Agreement, dated October 27, 2020, between the Company and Continental Stock Transfer & Trust Company, as warrant agent. (2)
10.1		Sponsor Letter Agreement, dated March 29, 2021, by and among Ajax I Holdings, LLC, Ajax I and Cazoo Holdings Limited.(1)
10.2*		Commitment Letter, dated May 15,2021, between the Company and Daniel Och.
10.3*		Commitment Letter, dated May 15,2021, between the Company and Glenn Fuhrman.
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer Pursuant and Principal Financial Officer to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		XBRL Instance Document
101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*		XBRL Taxonomy Extension Schema Document
101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

*	Filed herewith.
No.		Description of Exhibit
**	Furnished.
1.1		Underwriting Agreement, dated October 27, 2020, between the Company, Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC. (2)
(1)	Previously filed as an exhibit to our Current Report on Form 8-K filed on March 29, 2021 and incorporated by reference herein.
2.1		Business Combination Agreement, dated as of March 29, 2021, by and among Ajax I, Cazoo Holdings Limited and Capri Listco.(1)
(2)	Previously filed as an exhibit to our Current Report on Form 8-K filed on October 30, 2020 and incorporated by reference herein.
3.1		Amended and Restated Memorandum and Articles of Association of the Company. (2)
4.1		Warrant Agreement, dated October 27, 2020, between the Company and Continental Stock Transfer & Trust Company, as warrant agent. (2)
10.1		Sponsor Letter Agreement, dated March 29, 2021, by and among Ajax I Holdings, LLC, Ajax I and Cazoo Holdings Limited.(1)
10.2*		Commitment Letter, dated August 4,2021, between the Company and Daniel Och.
10.3*		Commitment Letter, dated August 4,2021, between the Company and Glenn Fuhrman.
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer Pursuant and Principal Financial Officer to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document.
101.SCH*		Inline XBRL Taxonomy Extension Schema Document.
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Filed herewith.
**	Furnished.
(1)	Previously filed as an exhibit to our Current Report on Form 8-K filed on March 29, 2021 and incorporated by reference herein.
(2)	Previously filed as an exhibit to our Current Report on Form 8-K filed on October 30, 2020 and incorporated by reference herein.

~~SIGNATURES~~25

~~Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.~~SIGNATURES

	AJAX I
Date: May 17, 2021		/s/ Daniel S. Och
	Name:	Daniel S. Och
	Title:	Chief Executive Officer
		(Principal Executive Officer)
Date: May 17, 2021		/s/ J. Morgan Rutman
	Name:	J. Morgan Rutman
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AJAX I

Date: August 12, 2021		/s/ Daniel S. Och
	Name:	Daniel S. Och
	Title:	Chief Executive Officer
		(Principal Executive Officer)

Date: August 12, 2021		/s/ J. Morgan Rutman
	Name:	J. Morgan Rutman
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

false --12-31 Q2 2021 0001824963 80499090 8944343 0001824963 2021-01-01 2021-06-30 0001824963 us-gaap:CommonClassAMember 2021-08-12 0001824963 us-gaap:CommonClassBMember 2021-08-12 0001824963 2021-06-30 0001824963 2020-12-31 0001824963 us-gaap:CommonClassAMember 2021-06-30 0001824963 us-gaap:CommonClassAMember 2020-12-31 0001824963 us-gaap:CommonClassBMember 2021-06-30 0001824963 us-gaap:CommonClassBMember 2020-12-31 0001824963 2021-04-01 2021-06-30 0001824963 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001824963 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001824963 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001824963 us-gaap:RetainedEarningsMember 2020-12-31 0001824963 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001824963 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001824963 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001824963 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001824963 2021-01-01 2021-03-31 0001824963 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001824963 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001824963 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001824963 us-gaap:RetainedEarningsMember 2021-03-31 0001824963 2021-03-31 0001824963 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001824963 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001824963 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001824963 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001824963 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001824963 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001824963 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001824963 us-gaap:RetainedEarningsMember 2021-06-30 0001824963 us-gaap:IPOMember 2020-10-10 2020-10-30 0001824963 us-gaap:OverAllotmentOptionMember 2020-10-10 2020-10-30 0001824963 us-gaap:OverAllotmentOptionMember 2020-10-30 0001824963 us-gaap:PrivatePlacementMember 2021-01-01 2021-06-30 0001824963 us-gaap:PrivatePlacementMember 2021-06-30 0001824963 ajax:BusinessCombinationMember 2021-06-30 0001824963 ajax:BusinessCombinationMember 2021-01-01 2021-06-30 0001824963 2021-03-01 2021-03-22 0001824963 2021-05-01 2021-05-15 0001824963 us-gaap:SubsequentEventMember 2021-08-04 0001824963 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001824963 us-gaap:CommonClassAMember 2021-04-01 2021-06-30 0001824963 ajax:NonRedeemableOrdinarySharesMember 2021-04-01 2021-06-30 0001824963 ajax:NonRedeemableOrdinarySharesMember 2021-01-01 2021-06-30 0001824963 us-gaap:IPOMember 2021-01-01 2021-06-30 0001824963 us-gaap:OverAllotmentOptionMember 2021-01-01 2021-06-30 0001824963 ajax:SponsorMember 2021-06-30 0001824963 ajax:SponsorsMember us-gaap:PrivatePlacementMember 2021-06-30 0001824963 ajax:SponsorsMember 2021-01-01 2021-06-30 0001824963 ajax:FounderSharesMember 2020-09-01 2020-09-16 0001824963 us-gaap:CommonClassBMember 2020-09-01 2020-09-22 0001824963 us-gaap:CommonClassBMember ajax:FounderSharesMember 2020-09-01 2020-09-22 0001824963 ajax:FounderSharesMember 2020-09-01 2020-09-22 0001824963 2020-10-10 2020-10-30 0001824963 2020-10-01 2020-10-27 0001824963 2020-09-16 0001824963 2020-10-30 0001824963 ajax:DanielOchAndGlennFuhrmanMember 2021-05-15 2021-05-15 0001824963 2021-05-15 2021-05-15 0001824963 us-gaap:CommonClassAMember 2021-06-30 0001824963 us-gaap:CommonClassBMember 2021-06-30 0001824963 us-gaap:CommonClassCMember 2021-06-30 0001824963 ajax:PIPEInvestorsMember 2021-03-01 2021-03-29 0001824963 us-gaap:CommonClassAMember 2021-03-01 2021-03-29 0001824963 us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001824963 ajax:BusinessCombinationMember us-gaap:CommonClassAMember 2021-06-30 0001824963 us-gaap:WarrantMember 2021-06-30 0001824963 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001824963 ajax:BlackScholesOptionPricingModelMember 2021-01-01 2021-06-30 0001824963 ajax:BlackScholesOptionPricingModelMember 2020-01-01 2020-12-31 0001824963 us-gaap:FairValueInputsLevel1Member 2021-06-30 0001824963 us-gaap:FairValueInputsLevel1Member 2020-12-31 0001824963 us-gaap:FairValueInputsLevel1Member ajax:PublicWarrantsMember 2021-01-01 2021-06-30 0001824963 us-gaap:FairValueInputsLevel1Member ajax:PublicWarrantsMember 2020-01-01 2020-12-31 0001824963 us-gaap:FairValueInputsLevel3Member us-gaap:PrivatePlacementMember 2021-01-01 2021-06-30 0001824963 us-gaap:FairValueInputsLevel3Member us-gaap:PrivatePlacementMember 2020-01-01 2020-12-31 0001824963 2020-01-01 2020-12-31 0001824963 us-gaap:CommonClassAMember 2020-01-01 2020-12-31 0001824963 us-gaap:PrivatePlacementMember 2020-12-31 0001824963 ajax:PublicMember 2020-12-31 0001824963 ajax:WarrantLiabilitiesMember 2020-12-31 0001824963 ajax:PublicMember 2021-01-01 2021-06-30 0001824963 ajax:WarrantLiabilitiesMember 2021-01-01 2021-06-30 0001824963 ajax:PublicMember 2021-06-30 0001824963 ajax:WarrantLiabilitiesMember 2021-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Filing Compare · Ajax I